United States - English - NLM (National Library of Medicine)

strides pharma science limited - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p), sodium sulfate anhydrous (unii: 36kcs0r750) (sodium sulfate anhydrous - unii:36kcs0r750), sodium bicarbonate (unii: 8mdf5v39qo) (sodium cation - unii:lyr4m0nh37, bicarbonate ion - unii:hn1zra3q20), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), potassium chlorate (unii: h35ks68ee7) (potassium cation - unii:295o53k152, chlorate ion - unii:08z8093742) - polyethylene glycol 3350 and electrolytes for oral solution is indicated for bowel cleansing prior to colonoscopy and barium enema x-ray examination in adults polyethylene glycol 3350 and electrolytes for oral solution, is contraindicated in the following conditions: -   gastrointestinal (gi) obstruction [see warnings and precautions (5.6)] -   bowel perforation [see warnings and precautions (5.6)] -   toxic colitis or toxic megacolon -   gastric retention -   ileus -   hypersensitivity to any component of polyethylene glycol 3350 and electrolytes for oral solution [see warnings and precautions (5.8)] animal reproduction studies have not been conducted with polyethylene glycol 3350 and electrolytes for oral solution. it is also not known whether polyethylene glycol 3350 and electrolytes for oral solution, can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. polyethylene glycol 3350 and electrolytes for oral solution, should be given to a pregnant woman only if clearl

United States - English - NLM (National Library of Medicine)

novel laboratories, inc. - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p), sodium sulfate anhydrous (unii: 36kcs0r750) (sodium sulfate anhydrous - unii:36kcs0r750), sodium bicarbonate (unii: 8mdf5v39qo) (sodium cation - unii:lyr4m0nh37), sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152) - polyethylene glycol 3350 236 g in 274.31 g - peg-3350 and electrolytes for oral solution is indicated for bowel cleansing prior to colonoscopy and barium enema x-ray examination in adults. peg-3350 and electrolytes for oral solution is contraindicated in the following conditions: - gastrointestinal (gi) obstruction (5.6) - bowel perforation (5.6) - toxic colitis or toxic megacolon - gastric retention - ileus - hypersensitivity to components of peg-3350 and electrolytes for oral solution (5.8) animal reproduction studies have not been conducted with peg-3350 and electrolytes for oral solution. it is also not known whether peg-3350 and electrolytes for oral solution can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. peg-3350 and electrolytes for oral solution should be given to a pregnant woman only if clearly needed. it is not known whether this drug is excreted in human milk. because many drugs are excreted in human milk, caution should be exercised when peg-3350 and electrolytes for oral solution is administ

United States - English - NLM (National Library of Medicine)

affordable pharmaceuticals, llc - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p), sodium sulfate anhydrous (unii: 36kcs0r750) (sodium cation - unii:lyr4m0nh37, sulfate ion - unii:7is9n8kpmg), sodium bicarbonate (unii: 8mdf5v39qo) (sodium cation - unii:lyr4m0nh37, bicarbonate ion - unii:hn1zra3q20), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q3 - polyethylene glycol 3350 236 g in 4 l - peg-3350 and electrolytes for oral solution is indicated for bowel cleansing prior to colonoscopy and barium enema x-ray examination in adults. peg-3350 and electrolytes for oral solution is contraindicated in the following conditions: - gastrointestinal (gi) obstruction [see warnings and precautions ( 5.6)] - bowel perforation [see warnings and precautions ( 5.6)] - toxic colitis or toxic megacolon - gastric retention - ileus - hypersensitivity to any component of peg-3350 and electrolytes for oral solution [see warnings and precautions ( 5.8)] animal reproduction studies have not been conducted with peg-3350 and electrolytes for oral solution. it is also not known whether peg-3350 and electrolytes for oral solution can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. peg-3350 and electrolytes for oral solution should be given to a pregnant woman only if clearly nee

Ireland - English - HPRA (Health Products Regulatory Authority)

baxter holding b.v. - alanine; arginine ; aspartic acid; glutamic acid ; glycine; histidine; isoleucine; leucine ; lysine acetate; methionine; phenylalanine; proline; serine; threonine; tryptophan; tyrosine; valine; magnesium chloride hexahydrate; potassium chloride; sodium acetate trihydrate ; sodium glycerophophate hydrate; glucose monohydrate; calcium chloride dihydrate; olive oil, refined; soya bean oil, refined ph.eur - emulsion for infusion - 12g/l nitrogen 950 kcal/l wtih electrolytes - solutions for parenteral nutrition; combinations

United States - English - NLM (National Library of Medicine)

oceanside pharmaceuticals - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p), sodium sulfate (unii: 0ypr65r21j) (sodium sulfate anhydrous - unii:36kcs0r750), sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152) - polyethylene glycol-3350, electrolytes, and ascorbate for oral solution is an osmotic laxative indicated for cleansing of the colon as a preparation for colonoscopy in adults. polyethylene glycol-3350, electrolytes, and ascorbate for oral solution is contraindicated in the following conditions: risk summary there are no available data on polyethylene glycol-3350, electrolytes, and ascorbate for oral solution in pregnant women to inform a drug-associated risk for adverse developmental outcomes. animal reproduction studies have not been conducted with polyethylene glycol-3350, electrolytes, and ascorbate for oral solution. the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively. risk summary the

New Zealand - English - Medsafe (Medicines Safety Authority)

intermed medical ltd - alanine 3.48 mg/ml; arginine 3.56 mg/ml; aspartic acid 2.45 mg/ml; calcium 0.005 meq/ml (electrolytes); chlorine 0.048 meq/ml (electrolytes); glucose 25%; glutamic acid 2.58 mg/ml; glycine 1.75 mg/ml; histidine 1.05 mg/ml; isoleucine 2.31 mg/ml; leucine 3.5 mg/ml; lysine 3.68 mg/ml (as lysine acetate with 0.0252meq/ml acetate ions); magnesium 0.005 meq/ml (electrolytes); methionine 0.6 mg/ml; phenylalanine 1.04 mg/ml; phosphorus 0.015 mmol/ml (electrolytes); potassium 0.033 meq/ml (electrolytes); proline 2.52 mg/ml; serine 1.86 mg/ml; sodium 0.04 meq/ml (electrolytes); threonine 1.4 mg/ml; tryptophan 0.7 mg/ml; tyrosine 0.94 mg/ml; valine 1.75 mg/ml - solution for infusion - 3.5 % - active: alanine 3.48 mg/ml arginine 3.56 mg/ml aspartic acid 2.45 mg/ml calcium 0.005 meq/ml (electrolytes) chlorine 0.048 meq/ml (electrolytes) glucose 25% glutamic acid 2.58 mg/ml glycine 1.75 mg/ml histidine 1.05 mg/ml isoleucine 2.31 mg/ml leucine 3.5 mg/ml lysine 3.68 mg/ml (as lysine acetate with 0.0252meq/ml acetate ions) magnesium 0.005 meq/ml (electrolytes) methionine 0.6 mg/ml phenylalanine 1.04 mg/ml phosphorus 0.015 mmol/ml (electrolytes) potassium 0.033 meq/ml (electrolytes) proline 2.52 mg/ml serine 1.86 mg/ml sodium 0.04 meq/ml (electrolytes) threonine 1.4 mg/ml tryptophan 0.7 mg/ml tyrosine 0.94 mg/ml valine 1.75 mg/ml

New Zealand - English - Medsafe (Medicines Safety Authority)

intermed medical ltd - alanine 4.22 mg/ml; arginine 4.32 mg/ml; aspartic acid 2.98 mg/ml; calcium 0.005 meq/ml (electrolytes); chlorine 0.048 meq/ml (electrolytes); glucose 20%; glutamic acid 3.14 mg/ml; glycine 2.12 mg/ml; histidine 1.28 mg/ml; isoleucine 2.8 mg/ml; leucine 4.25 mg/ml; lysine 4.46 mg/ml (as lysine acetate. includes 0.0306meq/ml acetate ions); magnesium 0.005 meq/ml (electrolytes); methionine 0.73 mg/ml; phenylalanine 1.26 mg/ml; phosphorus 0.015 mmol/ml (electrolytes); potassium 0.033 meq/ml (electrolytes); proline 2.52 mg/ml; serine 2.25 mg/ml; sodium 0.04 meq/ml (electrolytes); threonine 1.7 mg/ml; tryptophan 0.85 mg/ml; tyrosine 1.15 mg/ml; valine 2.12 mg/ml - solution for infusion - 4.25 % - active: alanine 4.22 mg/ml arginine 4.32 mg/ml aspartic acid 2.98 mg/ml calcium 0.005 meq/ml (electrolytes) chlorine 0.048 meq/ml (electrolytes) glucose 20% glutamic acid 3.14 mg/ml glycine 2.12 mg/ml histidine 1.28 mg/ml isoleucine 2.8 mg/ml leucine 4.25 mg/ml lysine 4.46 mg/ml (as lysine acetate. includes 0.0306meq/ml acetate ions) magnesium 0.005 meq/ml (electrolytes) methionine 0.73 mg/ml phenylalanine 1.26 mg/ml phosphorus 0.015 mmol/ml (electrolytes) potassium 0.033 meq/ml (electrolytes) proline 2.52 mg/ml serine 2.25 mg/ml sodium 0.04 meq/ml (electrolytes) threonine 1.7 mg/ml tryptophan 0.85 mg/ml tyrosine 1.15 mg/ml valine 2.12 mg/ml

New Zealand - English - Medsafe (Medicines Safety Authority)

intermed medical ltd - alanine 4.22 mg/ml; arginine 4.32 mg/ml; aspartic acid 2.98 mg/ml; calcium 0.0306 meq/ml (electrolytes); chlorine 0.048 meq/ml (electrolytes); glucose 25%; glutamic acid 3.14 mg/ml; glycine 2.12 mg/ml; histidine 1.28 mg/ml; isoleucine 2.8 mg/ml; leucine 4.25 mg/ml; lysine 4.46 mg/ml (as lysine acetate. includes 0.0252meq/ml acetate ions); magnesium 0.005 meq/ml (electrolytes); methionine 0.73 mg/ml; phenylalanine 1.26 mg/ml; phosphorus 0.015 mmol/ml (electrolytes); potassium 0.033 meq/ml (electrolytes); proline 3.07 mg/ml; serine 2.25 mg/ml; sodium 0.04 meq/ml (electrolytes); threonine 1.7 mg/ml; tryptophan 0.85 mg/ml; tyrosine 1.15 mg/ml; valine 2.12 mg/ml - solution for infusion - 4.25 % - active: alanine 4.22 mg/ml arginine 4.32 mg/ml aspartic acid 2.98 mg/ml calcium 0.0306 meq/ml (electrolytes) chlorine 0.048 meq/ml (electrolytes) glucose 25% glutamic acid 3.14 mg/ml glycine 2.12 mg/ml histidine 1.28 mg/ml isoleucine 2.8 mg/ml leucine 4.25 mg/ml lysine 4.46 mg/ml (as lysine acetate. includes 0.0252meq/ml acetate ions) magnesium 0.005 meq/ml (electrolytes) methionine 0.73 mg/ml phenylalanine 1.26 mg/ml phosphorus 0.015 mmol/ml (electrolytes) potassium 0.033 meq/ml (electrolytes) proline 3.07 mg/ml serine 2.25 mg/ml sodium 0.04 meq/ml (electrolytes) threonine 1.7 mg/ml tryptophan 0.85 mg/ml tyrosine 1.15 mg/ml valine 2.12 mg/ml

Israel - English - Ministry of Health

teva medical marketing ltd. - glucose as monohydrate; sodium chloride - solution for injection - sodium chloride 4.5 mg/ml; glucose as monohydrate 50 mg/ml - electrolytes - electrolytes - provides electrolytes and calories and is a source of water for hydration.

United States - English - NLM (National Library of Medicine)

hospira, inc. - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838, chloride ion - unii:q32zn48698), sodium acetate anhydrous (unii: nvg71zz7p0) (sodium cation - unii:lyr4m0nh37, acetate ion - unii:569dqm74sc) - sodium chloride 321 mg in 20 ml - tpn electrolytes (multiple electrolyte additive) is indicated for use as a supplement to nutritional solutions containing concentrated dextrose and amino acids delivered by central venous infusion, to help maintain electrolyte homeostasis in adult patients. tpn electrolytes (multiple electrolyte additive) is contraindicated in pathological conditions where additives of potassium, sodium, calcium, magnesium or chloride could be clinically deleterious, e.g., anuria, hyperkalemia, heart block or myocardial damage and severe edema due to cardiovascular, renal or hepatic failure. none known.